Russian Federation
6 Vaccines Approved for Use in Russian Federation
Protein Subunit
Vector State Research Center of Virology and Biotechnology
Aurora-CoV
Approved in 1 country
2 trials in 1 country
Approval Source: interfax.com
Protein Subunit
Vector State Research Center of Virology and Biotechnology
EpiVacCorona
Approved in 4 countries
4 trials in 1 country
Approval Source: cnbc.com
Non Replicating Viral Vector
Gamaleya
Sputnik V
Approved in 74 countries
24 trials in 7 countries
Approval Source: theguardian.com
Non Replicating Viral Vector
Inactivated
Chumakov Center
KoviVac
Approved in 3 countries
3 trials in 1 country
Approval Source: grls.rosminzdrav.ru
Non Replicating Viral Vector
11 in Clinical Trials in Russian Federation
Protein Subunit
Vector State Research Center of Virology and Biotechnology
EpiVacCorona
Approved in 4 countries
4 trials in 1 country
Non Replicating Viral Vector
CanSino
Convidecia
Approved in 10 countries
13 trials in 6 countries
Non Replicating Viral Vector
Gamaleya
Sputnik Light
Approved in 26 countries
7 trials in 3 countries
Non Replicating Viral Vector
Gamaleya
Sputnik V
Approved in 74 countries
24 trials in 7 countries
Non Replicating Viral Vector
Oxford/AstraZeneca
Vaxzevria
Approved in 140 countries
64 trials in 31 countries
Protein Subunit
Human Stem Cell Institute Russia
Betuvax-CoV-2
2 trials in 1 country
Protein Subunit
St. Petersburg Research Institute of Vaccines and Sera
Recombinant subunit vaccine
2 trials in 1 country
Protein Subunit
Vector State Research Center of Virology and Biotechnology
Aurora-CoV
Approved in 1 country
2 trials in 1 country
Non Replicating Viral Vector
Biocad
BCD-250
2 trials in 1 country
Non Replicating Viral Vector
Institute of Vaccines and Medical Biologicals
COVIVAC
4 trials in 2 countries
Inactivated
Chumakov Center
KoviVac
Approved in 3 countries
3 trials in 1 country